Healthy Extracts (Healthy Extracts) Debt-to-Equity : 7.64 (As of Mar. 2024)

View and export this data going back to 2015. Start your Free Trial

What is Healthy Extracts Debt-to-Equity?

Healthy Extracts's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was $1.16 Mil. Healthy Extracts's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was $0.00 Mil. Healthy Extracts's Total Stockholders Equity for the quarter that ended in Mar. 2024 was $0.15 Mil. Healthy Extracts's debt to equity for the quarter that ended in Mar. 2024 was 7.64.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Healthy Extracts's Debt-to-Equity or its related term are showing as below:

HYEX' s Debt-to-Equity Range Over the Past 10 Years
Min: -3.05 Med: -0.06 Max: 1.18
Current: 1.18

During the past 10 years, the highest Debt-to-Equity Ratio of Healthy Extracts was 1.18. The lowest was -3.05. And the median was -0.06.

HYEX's Debt-to-Equity is ranked worse than
88.56% of 848 companies
in the Drug Manufacturers industry
Industry Median: 0.29 vs HYEX: 1.18

Healthy Extracts Debt-to-Equity Historical Data

The historical data trend for Healthy Extracts's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Healthy Extracts Debt-to-Equity Chart

Healthy Extracts Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Debt-to-Equity

Get a 7-Day Free Trial

-3.05

0.06

0.14

0.32

1.18

Healthy Extracts Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Debt-to-Equity	Get a 7-Day Free Trial															0.82	0.95	1.14	1.18	7.64

Competitive Comparison of Healthy Extracts's Debt-to-Equity

For the Drug Manufacturers - Specialty & Generic subindustry, Healthy Extracts's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Healthy Extracts's Debt-to-Equity Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Healthy Extracts's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Healthy Extracts's Debt-to-Equity falls into.

Healthy Extracts Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Healthy Extracts's Debt to Equity Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(1.128	+	0)	/	0.955
	=	1.18

Healthy Extracts's Debt to Equity Ratio for the quarter that ended in Mar. 2024 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(1.161	+	0)	/	0.152
	=	7.64

Healthy Extracts (OTCPK:HYEX) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

Healthy Extracts Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Healthy Extracts's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Healthy Extracts (Healthy Extracts) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Healthy Extracts Inc (OTCPK:HYEX) » Definitions » Debt-to-Equity

Comparable Companies

Traded in Other Exchanges

N/A

Address

7375 Commercial Way, Suite 125, Henderson, NV, USA, 89011

Website

https://www.healthyextractsinc.com

Healthy Extracts Inc through its subsidiaries is engaged in proprietary research and development of natural plant-based formulations, manufacturing, sales, and distribution of cardiovascular and neuro products that provide natural brain solutions. The company also provides superfruit supplements to support overall cholesterol and cardiovascular health. Its products are distributed in the United States and Mexico. The company's operating segment includes Health Supplements and Corporate. It generates maximum revenue from the Health Supplements segment.

Executives

Robert Michael Madden	officer: Chief Financial Officer	5269 SOUTH ALVERA CIR, SALT LAKE CITY UT 84117
Croyle William Russell Jr	director	1 SILVERMOUND, LITTLETON CO 80127
Kevin Pitts	10 percent owner, officer: President	3664 CHRISTY RIDGE RD., SEDALIA CO 80135
Sanjeevkumar Ratanshi Javia	director, officer: President	7161 E. RANCHO VISTA DRIVE, SUITE 3008, SCOTTSDALE AZ 85251
Patrick Stiles	director, 10 percent owner, officer: President, CEO	10300 W. CHARLESTON, LAS VEGAS NV 89135
Joseph Nejman	director, 10 percent owner, officer: President	555 BRYANT ST., SUITE 555, PALO ALTO CA 94301
William C Bossung	director, 10 percent owner, officer: CFO and Secretary	10300 W. CHARLESTON BLVD., STE. 13-378, LAS VEGAS NV 89135
Brian J Dunn	director, 10 percent owner	7075 FLYING CLOUD DRIVE, EDEN PRAIRIE MN 55344
Fred Covely	director, 10 percent owner, officer: President and CEO	1508 GRANDVIEW RD., VISTA CA 92084